122 related articles for article (PubMed ID: 18310171)
1. Clinical outcomes after an unstructured treatment interruption in children and adolescents with perinatally acquired HIV infection.
Saitoh A; Foca M; Viani RM; Heffernan-Vacca S; Vaida F; Lujan-Zilbermann J; Emmanuel PJ; Deville JG; Spector SA
Pediatrics; 2008 Mar; 121(3):e513-21. PubMed ID: 18310171
[TBL] [Abstract][Full Text] [Related]
2. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
[TBL] [Abstract][Full Text] [Related]
3. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia.
Bartlett AW; Lumbiganon P; Kurniati N; Sudjaritruk T; Mohamed TJ; Hansudewechakul R; Ly PS; Truong KH; Puthanakit T; Nguyen LV; Chokephaibulkit K; Do VC; Kumarasamy N; Nik Yusoff NK; Fong MS; Watu DK; Nallusamy R; Sohn AH; Law MG;
J Adolesc Health; 2019 Nov; 65(5):651-659. PubMed ID: 31395514
[TBL] [Abstract][Full Text] [Related]
4. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
5. [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
Pavie J; Porcher R; Fournier S; André F; Tournoux C; Palmer P; Rabian C; Jean-Michel M
Presse Med; 2005 Jun; 34(10 Suppl):1S8-13. PubMed ID: 16025661
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
7. Response to planned treatment interruptions in HIV infection varies across childhood.
Paediatric European Network for Treatment of AIDS
AIDS; 2010 Jan; 24(2):231-41. PubMed ID: 20010073
[TBL] [Abstract][Full Text] [Related]
8. Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
Gibb DM; Duong T; Leclezio VA; Walker AS; Verweel G; Dunn DT;
Pediatr Infect Dis J; 2004 May; 23(5):446-50. PubMed ID: 15131469
[TBL] [Abstract][Full Text] [Related]
9. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
[TBL] [Abstract][Full Text] [Related]
11. CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
Siberry GK; Patel K; Van Dyke RB; Hazra R; Burchett SK; Spector SA; Paul ME; Read JS; Wiznia A; Seage GR;
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):223-9. PubMed ID: 21423022
[TBL] [Abstract][Full Text] [Related]
12. CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.
Mussini C; Bedini A; Borghi V; Guaraldi G; Esposito R; Barchi E; Enilia R; Cozzi-Lepri A; Philips AN; Ortolani P; Bratt G; Eriksson LE; Sighinolfi L; Cossarizza A; d'Arminio Monforte A; De Luca A; Di Giambenedetto S; Antinori A;
AIDS; 2005 Feb; 19(3):287-94. PubMed ID: 15718839
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic Follow-up of Perinatally HIV-infected Children and Adolescents: Results From a Single-center Retrospective Cohort Study in Brazil.
Vallilo NG; Durigon GS; Lianza AC; de Fátima Rodrigues Diniz M; Shiraishi Sawamura KS; Brito CR; de Souza Marques HH; Ferraro AA; Leal GN
Pediatr Infect Dis J; 2020 Jun; 39(6):526-532. PubMed ID: 32412728
[TBL] [Abstract][Full Text] [Related]
15. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
[TBL] [Abstract][Full Text] [Related]
16. Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection.
Monpoux F; Tricoire J; Lalande M; Reliquet V; Bebin B; Thuret I
AIDS; 2004 Dec; 18(18):2401-9. PubMed ID: 15622316
[TBL] [Abstract][Full Text] [Related]
17. Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.
Aboulker JP; Babiker A; Chaix ML; Compagnucci A; Darbyshire J; Debré M; Faye A; Giaquinto C; Gibb DM; Harper L; Saïdi Y; Walker AS;
AIDS; 2004 Jan; 18(2):237-45. PubMed ID: 15075541
[TBL] [Abstract][Full Text] [Related]
18. Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial.
Maggiolo F; Ripamonti D; Gregis G; Quinzan G; Callegaro A; Suter F
AIDS; 2004 Feb; 18(3):439-46. PubMed ID: 15090796
[TBL] [Abstract][Full Text] [Related]
19. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
[TBL] [Abstract][Full Text] [Related]
20. Thymic volume predicts CD4 T-cell decline in HIV-infected adults under prolonged treatment interruption.
Molina-Pinelo S; Vivancos J; De Felipe B; Soriano-Sarabia N; Valladares A; De la Rosa R; Vallejo A; Leal M
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):203-6. PubMed ID: 16760798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
